Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Depelestat in Persistent ARDS
NCT00455767Phase 2Completed
- Sponsor
- Debiopharm
- Start
- Jul 2006
- Primary completion
- Sep 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 4
01
Overview
A Phase 2 trial of depelestat in acute respiratory distress syndrome (ARDS), sponsored by Debiopharm. Started Jul 2006; status: completed.
02
Drugs
depelestat
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT00455767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00455767.